Scientific Online Resource System

Biomedical Reviews

Translatability of (hemi)orchidectomized mouse model for male hypogonadism: A revision on clinical chemistry with an emphasis on xanthine oxidase of selected tissues

Ferdous Karimizand, Isaac Karimi, Shahrbanoo Oryan, Mohammad Nasrollahzadeh Masouleh

Abstract

Male hypogonadism is a prevalent syndrome with various clinical manifestations and ambiguity in its etiology and therapy. We investigated translatability and xanthine oxidase (XO) activity in a mouse model of hypogonadism. In this experimental study, 24 NMRI male mice were allocated into four groups: normal control (NC), bilateral orchidectomiezed (BOX), right hemi-orchi-dectomiezed (ROX), and left hemi-orchidectomiezed (LOX) mice. After eight weeks, plasma clinical chemistry and XO activities of selected tissues were measured. Plasma testosterone levels and bone mass density tended to decrease in (hemi)orchidecto-mized mice. The atherogenic index and coronary heart disease risk factor have not been altered in hemi-orchidectomized mice while it increased in orchidectomized mice. Plasma cholesterol has been increased in LOX (P=0.011) and BOX (P=0.041) compared to NC. Plasma calcium and phosphorus levels have not been changed in (hemi)orchidectomized mice as compared to NC. The globulin levels raised significantly in ROX (P=0.043) compared to NC while its levels tended to increase in BOX and LOX compared to NC. The activities of aspartate transaminase, alanine transaminase, and lactate dehydrogenase, and plasma and bone alkaline phosphatase were not different among groups. The XO activity tended to decrease in all tissues however, it sig-nificantly decreased in muscles of ROX (P=0.040) and BOX (P=0.047) with respect to NC. The XO activity has also decreased significantly in the heart tissues of LOX (P=0.045) and BOX (P=0.043) as compared to that of NC. It seems that more than 8 weeks post-orchidectomy time is required to translate male hypogonadism. Furthermore, XO activities were reduced in selected tissues following bilateral or unilateral orchidectomy.

Keywords

testosterone, osteoporosis, xanthine oxidase, alkaline phosphatase, hypogonadism

Full Text


References

Schwarz ER, Phan A, Willix Jr RD. Andropause and the development of cardiovascular disease presentation -more than an epi-phenomenon. J Geriatr Cardiol 2011; 8: 35-43. DOI: 10.3724/SP.J.1263.2011.00035

Saad F, Aversa A, Isidori AM, Gooren LJ. Testosterone as potential effective therapy in treatment of obesity in men with testosterone deficiency: a review. Curr Diab Rev 2012; 8: 131-143. DOI: 10.2174/157339912799424573

Brawer MK. Testosterone replacement in men with andropause: an overview. Rev Urol 2004; 6: S9-S15. PMID: 16985914;PMCID: PMC1472881

Saalu LC, Osinubi AA. Andropause (male menopause): valid concepts, fables and controversies. J Basic Med Sci 2013; 1: 33-37. Corpus ID: 78722056

Kim SH. Testosterone replacement therapy and bone mineral density in men with hypogonadism. En-docrinol Metab 2014; 29: 30-32. DOI: 10.3803/EnM.2014.29.1.30

Morley JE, Charlton E, Patrick P, Kaiser FE, Cadeau P, McCready D, et al. Validation of a screening ques-tionnaire for androgen deficiency in aging males. Metabolism 2000; 49: 1239–1242. DOI: 10.1053/meta.2000.8625.

Petak SM, Nankin HR, Spark RF, Swerdloff RS, Rodriguez-Rigau LJ. American Association of Clini-cal Endocrinologists. Hypogonadism Guidelines, American association of clinical endocrinologists medical guidelines for clinical practice for the evalua-tion and treatment of hypogonadism in adult male pa-tients - 2002 update. Endocr Pract 2002; 8: 439-456. PMID: 15260010

Matsumoto AM. Andropause: clinical implications of the decline in serum testosterone levels with aging in men. J Gerontol A Biol Sci Med Sci 57: M76–M99. DOI:10.1093/gerona/57.2.M76

Wespes E, Schulman CC. Male andropause: myth, real-ity, and treatment. Int J Impot Res 2002; 14: S93–S98. DOI:10.1038/sj.ijir.3900798.

Verma P, Mahajan KK, Mittal S. Andropause - a debat-able physiological process. JK Science J Med Educ Res 2006; 8: 68-72.

Tostes RC, Carneiro FS, Carvalho MHC, Reckelhoff JF. Reactive oxygen species: players in the cardiovas-cular effects of testosterone. Am J Physiol Regul In-tegr Comp Physiol 2016; 310: R1–R14. DOI:10.1152/ajpregu.00392.2014

Motamedi S, Karimi I, Jafari F. The interrelationship of metabolic syndrome and neurodegenerative disease: fo-cus on brain-derived neurotrophic factor. Metab Brain Dis 2017. DOI:10.1007/s11011-017-9997-0

Villareal DT, Apovian CM, Kushner RF, Klein S. Obesity in older adults: technical review and position statement of the American Society for Nutrition and NAASO, The Obesity Society. Am J ClinNutr 2005; 82: 923–934. DOI: 10.1093/ajcn/82.5.923

Sofimajidpour H, Teimoori T, Gharibi F. The effect of testosterone on men with andropause. Iran Red Crescent Med J 2015; 17: e19406. DOI: 10.5812/ircmj.19406

Jang H, Bae WJ, Kim SJ, Yuk SM, Han DS, Ha US, et al. The effect of anthocyanin on the prostate in an andropause animal model: rapid prostatic cell death by apoptosis is partially prevented by anthocyanin sup-plementation. World J Mens Health 2013; 31: 239-

DOI: 10.5534/wjmh.2013.31.3.239

Khosla S, Atkinson EJ, Dunstan CR, O’Fallon WM. Ef-fect of estrogen versus testosterone on circulating osteo-protegerin and other cytokine levels in normal elderly men. J Clin Endocrinol Metab 2002; 87:1550-1554

Graves DT, Oates T Garlet GP. Review of osteoimmu-nology and the host response in endodontic and perio-dontal lesions. J Oral Microbiol 2011; 3: DOI: 10.3402/jom.v3i0.5304

Ismail M, Al-Taher AY. Effect of propetamphos on the male rats reproductive system. Environ Toxicol Pharma-col 2011; 31: 333-338. DOI: 10.1016/j.etap.2011.01.001

Dawson J, Walters M. Uric acid and xanthine oxidase: future therapeutic targets in the prevention of cardiovas-cular disease? Br J Clin Pharmacol 2006; 62: 633-644. DOI: 10.1111/j.1365-2125.2006.02785.x

Khany A, Karimi I, Alimoradian D, Zavareh S. Distri-bution of xanthine oxidase in selected tissues of a mouse model of menopause. J Chem Health Res 2016; 6: 225-235.

Feig DI, Kang DH, Richard J. Johnson RJ. Uric acid and cardiovascular risk. N Engl J Med 2008; 359: 1811–1821. DOI: 10.1056/NEJMra0800885

Friedewald WT, Ley RI, Fradrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentri-fuge. Clin Chem 1972; 18: 499–502. PMID: 4337382

Lee R, Niemann D. Nutritional assessment. Mosby, Missouri. 1996.

Kinosian B, Glick H, Garland G. Cholesterol and coro-nary heart disease: predicting risks by levels and ratios. Ann Intern Med 1994; 121: 641–664. PMID: 8528755

Naseri D, Asasi K, Karimi I. Similar developmental fluctuations of hepato-renal xanthine oxidoreductase gene expression and xanthine oxidase activity in layer and broiler chicken embryos. Br Poult Sci 2017; 58 (2):

- 150. DOI: 10.1080/00071668.2016.1268250

Bradford MM. Rapid and sensitive method for the quan-titation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 248–254. DOI: 10.1006/abio.1976.9999

Isayama RN, Oishi J, Cagnon VHA, Campos GER. Ef-fect of testosterone on skeletal muscle of young and old male rats. Braz J Morphol Sci 2006; 23: 247-253.

Carnegie C. Diagnosis of hypogonadism: clinical as-sessments and laboratory tests. Rev Uro 2004; 6(Suppl 6): S3-S8. PMID: 16985909

Fahed AC, Gholmieh JM, Azar ST. Connecting the lines between hypogonadism and atherosclerosis. Int J Endo-crinol 2012; 793953. DOI:10.1155/2012/793953

Sheehy CM, Perry PA, Cromwell SL. Dehydration: biological considerations, age-related changes, and risk factors in older adults. Biol Res Nurs 1999; 1(1):30-37. DOI: 10.1177/109980049900100105

Cappola TP, Kass DA, Nelson GS, Berger RD, Rosas GO, Kobeissi ZA, et al. Allopurinol improves myo-cardial efficiency in patients with idiopathic dilated cardiomyopathy. Circulation 2001; 104: 2407-2411. DOI:10.1161/hc4501.098928

Higgins P, Dawson J, Lees KR, McArthur K, Quinn TJ, Walters MR. Xanthine oxidase inhibition for the treat-ment of cardiovascular disease: a systematic review and meta-analysis. Cardiovasc Ther 2012; 30:217–226. DOI:10.1111/j.1755-5922.2011.00277.x

Lin C-Y, Lin M-T, Cheng R-T, Chen S-H. Testosterone depletion by castration may protect mice from heat-in-duced multiple organ damage and lethality. J Biomed Biotech 2010; 485306. DOI:10.1155/2010/485306

Powers SK, Kavazis AN, De Ruisseau KC. Mechanisms of disuse muscle atrophy: role of oxidative stress. Am J Physiol Regul Integr Comp Physiol 2005; 288: R337-R344. DOI: 10.1152/ajpregu.00469.2004

Bravard A, Bonnard C, Durand A, Chauvin MA, Favier R, Vidal H, et al. Inhibition of xanthine oxidase reduces hyperglycemia-induced oxidative stress and improves mitochondrial alterations in skeletal muscle of diabetic mice. Am J Physiol Endocrinol Metab 2011; 300: E581-E591. DOI: 10.1152/ajpendo.00455.2010

Kumagai A, Kodama H, Kumagai J, Fukuda J, Kawa-mura K, Tanikawa H, et al. Xanthine oxidase inhibitors suppress testicular germ cell apoptosis induced by ex-perimental cryptorchidism. Mol Human Reprod 2002; 8(1): 118–123. DOI:10.1093/molehr/8.2.118




DOI: http://dx.doi.org/10.14748/bmr.v32.8505

Refbacks

Article Tools
Email this article (Login required)
About The Authors

Ferdous Karimizand
Department of Biology, Faculty of Science, Science and Research Branch of Islamic Azad University, Tehran, Iran
Iran, Islamic Republic of

Isaac Karimi
Department of Biology, Faculty of Science, Razi University, Kermanshah, Iran Laboratory of Molecular and Cellular Biology 1214, Department of Basic Veterinary Sciences, School of Veterinary Medicine, Razi University, Kermanshah, Iran
Iran, Islamic Republic of

Shahrbanoo Oryan
Department of Biology, Faculty of Science, Kharazmi University, Tehran, Iran
Iran, Islamic Republic of

Mohammad Nasrollahzadeh Masouleh
Department of Small Animal Internal Medicine and Radiology, Science and Research Branch, Islamic Azad University, Tehran, Iran
Iran, Islamic Republic of

Font Size


|